DOI: https://doi.org/10.22141/2312-413x.6.6.2018.151481

Clinical and epidemiological features of the course of rotavirus infection and the justification of its prevention in children

L.O. Yushchenko, O.V. Oniskova, V.О. Tikholaz, G.G. Odnorogova, O.O. Gordiychuk, V.I. Bulavenko

Abstract


It was found that rotavirus infection occupies a large part among infectious gastroenteritis in children, with an increasing the incidences in winter and spring. We have studied the main clinical and diagnostic characteristics of rotavirus gastroenteritis. Dyspeptic disorders, intoxication and dehydration symptoms dominated among the clinical manifestations in children. It was found that none of the hospitalized patients received specific prevention of rotavirus infection, while vaccination is the most effective and safe method of prevention. That is why the ways of vaccination against rotavirus infection in Ukraine should be considered.

Keywords


rotavirus infection; children; vaccination; prevention

References


Aliabadi N, Tate JE, Haynes AK, Parashar UD; Centers for Disease Control and Prevention (CDC). Sustained decrease in laboratory detection of rotavirus after implementation of routine vaccination-United States, 2000-2014. MMWR Morb Mortal Wkly Rep. 2015 Apr 10;64(13):337-42.

Christie CD, Duncan ND, Thame KA, et al. Pentavalent rotavirus vaccine in developing countries: safety and health care resource utilization. Pediatrics. 2010 Dec;126(6):e1499-506. doi: 10.1542/peds.2010-1240.

Sanderson C, Clark A, Taylor D, Bolanos B. Global review of rotavirus morbidity and mortality data by age and region. London: London School of Hygiene & Tropical Medicine; 2011. 42 p.

Cortes JE, Curns AT, Tate JE, et al. Rotavirus vaccine and health care utilization for diarrhea in U.S. children. N Engl J Med. 2011 Sep 22;365(12):1108-17. doi: 10.1056/NEJMoa1000446.

Danchin MH, Bines JE. Defeating rotavirus? The global recommendation for rotavirus vaccination. N Engl J Med. 2009 Nov 12;361(20):1919-21. doi: 10.1056/NEJMp0905091.

Dash N, Verma S. Pertussis and Rotavirus Vaccines - Controversies and Solutions. Indian J Pediatr. 2018 Jan;85(1):53-59. doi: 10.1007/s12098-017-2393-2.

Dennehy PH, Bertrand HR, Silas PE, Damaso S, Friedland LR, Abu-Elyazeed R. Coadministration of RIX4414 oral human rotavirus vaccine does not impact the immune response to antigens contained in routine infant vaccines in the United States. Pediatrics. 2008 Nov;122(5):e1062-6. doi: 10.1542/peds.2008-1059.

Gastañaduy PA, Curns AT, Parashar UD, Lopman BA. Gastroenteritis hospitalizations in older children and adults in the United States before and after implementation of infant rotavirus vaccination. JAMA. 2013 Aug 28;310(8):851-3. doi: 10.1001/jama.2013.170800.

Global Advisory Committee on Vaccine Safety, December 2011. Wkly Epidemiol Rec. 2012 Feb 10;87(6):53-9.

Gruber JF, Gruber LM, Weber RP, Becker-Dreps S, Jonsson Funk M. Rotavirus Vaccine Schedules and Vaccine Response Among Infants in Low- and Middle-Income Countries: A Systematic Review. Open Forum Infect Dis. 2017 Apr 5;4(2):ofx066. doi: 10.1093/ofid/ofx066.

Guarino A, Ashkenazi S, Gendrel D, et al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition/European Society for Pediatric Infectious Diseases evidence-based guidelines for the management of acute gastroenteritis in children in Europe: update 2014. J Pediatr Gastroenterol Nutr. 2014 Jul;59(1):132-52. doi: 10.1097/MPG.0000000000000375.

Haber P, Patel M, Izurieta HS, et al. Postlicensure monitoring of intussusception after RotaTeq vaccination in the United States, February 1, 2006, to September 25, 2007. Pediatrics. 2008 Jun;121(6):1206-12. doi: 10.1542/peds.2007-3793.

Isanaka S, Guindo O, Langendorf C, et al. Efficacy of a Low-Cost, Heat-Stable Oral Rotavirus Vaccine in Niger. N Engl J Med. 2017 Mar 23;376(12):1121-1130. doi: 10.1056/NEJMoa1609462.

Jonesteller CL, Burnett E, Yen C, Tate JE, Parashar UD. Effectiveness of Rotavirus Vaccination: A Systematic Review of the First Decade of Global Postlicensure Data, 2006-2016. Clin Infect Dis. 2017 Sep 1;65(5):840-850. doi: 10.1093/cid/cix369.

Karafillakis E, Hassounah S, Atchison C. Effectiveness and impact of rotavirus vaccines in Europe, 2006-2014. Vaccine. 2015 Apr 27;33(18):2097-107. doi: 10.1016/j.vaccine.2015.03.016.

Kotirum S, Vutipongsatorn N, Kongpakwattana K, Hutubessy R, Chaiyakunapruk N. Global economic evaluations of rotavirus vaccines: A systematic review. Vaccine. 2017 Jun 8;35(26):3364-3386. doi: 10.1016/j.vaccine.2017.04.051.

Lamberti LM, Ashraf S, Walker CL, Black RE. A Systematic Review of the Effect of Rotavirus Vaccination on Diarrhea Outcomes Among Children Younger Than 5 Years. Pediatr Infect Dis J. 2016 Sep;35(9):992-8. doi: 10.1097/INF.0000000000001232.

Libster R, McNeal M, Walter EB, et al. Safety and Immunogenicity of Sequential Rotavirus Vaccine Schedules. Pediatrics. 2016 Feb;137(2):e20152603. doi: 10.1542/peds.2015-2603.

Luchs A, Timenetsky Mdo C. Group A rotavirus gastroenteritis: post-vaccine era, genotypes and zoonotic transmission. Einstein (Sao Paulo). 2016 Apr-Jun;14(2):278-87. doi: 10.1590/S1679-45082016RB3582.

Madhi SA, Cunliffe NA, Steele D, et al. Effect of human rotavirus vaccine on severe diarrhea in African infants. N Engl J Med. 2010 Jan 28;362(4):289-98. doi: 10.1056/NEJMoa0904797.

Madhi SA, Kirsten M, Louw C, et al. A Efficacy and immunogenicity of two or three dose rotavirus-vaccine regimen in South African children over two consecutive rotavirus-seasons: a randomized, double-blind, placebo-controlled trial. Vaccine. 2012 Apr 27;30 Suppl 1:A44-51. doi: 10.1016/j.vaccine.2011.08.080.

Martinón-Torres F, Greenberg D, Varman M, Killar JA, Hille D, Strable EL et al. Safety, Tolerability and Immunogenicity of Pentavalent Rotavirus Vaccine Manufactured by a Modified Process. Pediatr Infect Dis J. 2017 Apr;36(4):417-422. doi: 10.1097/INF.0000000000001511.

Patel MM, López-Collada VR, Bulhões MM, et al. Intussusception risk and health benefits of rotavirus vaccination in Mexico and Brazil. N Engl J Med. 2011 Jun 16;364(24):2283-92. doi: 10.1056/NEJMoa1012952.

Payne DC, Selvarangan R, Azimi PH, et al. Long-term Consistency in Rotavirus Vaccine Protection: RV5 and RV1 Vaccine Effectiveness in US Children, 2012-2013. Clin Infect Dis. 2015 Dec 15;61(12):1792-9. doi: 10.1093/cid/civ872.

Pollard SL, Malpica-Llanos T, Friberg IK, Fischer-Walker C, Ashraf S, Walker N. Estimating the herd immunity effect of rotavirus vaccine. Vaccine. 2015 Jul 31;33(32):3795-800. doi: 10.1016/j.vaccine.2015.06.064.

Rotavirus vaccines. WHO position paper – January 2013. Wkly Epidemiol Rec. 2013 Feb 1;88(5):49-64.

Sana Fatima, Nuzhath Irfana, Sabiha Mirza Mushtaq, et al. A Cross-Sectional Study to Assess Prevalence and Management of Acute Gastroenteritis in Pediatric Inpatients of A Large Teaching Hospital. IOSR Journal Of Pharmacy. 2014 Dec; 4(12):12-26.

Santos VS, Marques DP, Martins-Filho PR, Cuevas LE, Gurgel RQ. Effectiveness of rotavirus vaccines against rotavirus infection and hospitalization in Latin America: systematic review and meta-analysis. Infect Dis Poverty. 2016 Aug 12;5(1):83. doi: 10.1186/s40249-016-0173-2.

Soares-Weiser K, Maclehose H, Bergman H, et al. Vaccines for preventing rotavirus diarrhoea: vaccines in use. Cochrane Database Syst Rev. 2012 Nov 14;11:CD008521. doi: 10.1002/14651858.CD008521.pub3.

Tissera MS, Cowley D, Bogdanovic-Sakran N, et al. Options for improving effectiveness of rotavirus vaccines in developing countries. Hum Vaccin Immunother. 2017 Apr 3;13(4):921-927. doi: 10.1080/21645515.2016.1252493.

Todd S, Page NA, Duncan Steele A, Peenze I, Cunliffe NA. Rotavirus strain types circulating in Africa: Review of studies published during 1997-2006. J Infect Dis. 2010 Sep 1;202 Suppl:S34-42. doi: 10.1086/653555.

Velázquez RF, Linhares AC, Muñoz S, et al. Efficacy, safety and effectiveness of licensed rotavirus vaccines: a systematic review and meta-analysis for Latin America and the Caribbean. BMC Pediatr. 2017 Jan 13;17(1):14. doi: 10.1186/s12887-016-0771-y.

Vesikari T, Karvonen A, Ferrante SA, Ciarlet M. Efficacy of the pentavalent rotavirus vaccine, RotaTeq®, in Finnish infants up to 3 years of age: the Finnish Extension Study. Eur J Pediatr. 2010 Nov;169(11):1379-86. doi: 10.1007/s00431-010-1242-3.

Vesikari T. Intussusception after human rotavirus vaccine. Pediatr Infect Dis J. 2013 May;32(5):579-80. doi: 10.1097/INF.0b013e318278bb4e.

Wang FT, Mast TC, Glass RJ, Loughlin J, Seeger JD. Effectiveness of an incomplete RotaTeq (RV5) vaccination regimen in preventing rotavirus gastroenteritis in the United States. Pediatr Infect Dis J. 2013 Mar;32(3):278-83. doi: 10.1097/INF.0b013e318275328f.




Copyright (c) 2018 ACTUAL INFECTOLOGY

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

© Publishing House Zaslavsky, 1997-2018

 

   Seo анализ сайта